The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 06, 2026
Snapshot (as of Jul 06, 2026): GE HealthCare Technologies Inc. (GEHC) pays a $0.14 annual dividend ($0.04 quarterly), yielding 0.21% at $65.56/share. Next ex-dividend date 2026-07-24. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.21%
Annual Dividend: $0.14 per share
Payout Ratio: 4.3%
Ex-Dividend Date: 2026-07-24
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 4
GE HealthCare Technologies Inc. dividend currently yields 0.21%, reflecting the company's early-stage payout on a global medical technology business spanning imaging systems, ultrasound, patient monitoring, and pharmaceutical diagnostics. GEHC pays dividends quarterly, with a trailing annual rate of $0.14 per share and an ex-dividend date of July 24, 2026. The company was established in 2022 and serves markets across North America, Europe, the Middle East, Africa, and Asia. With a beta of 0.839, GEHC stock carries below-market price volatility, which suits growth-and-income investors who prioritize dividend growth over immediate yield.
GE HealthCare Technologies Inc. pays out 4.3% of earnings as dividends, a payout ratio classified as conservative (below 40%). That figure leaves substantial room to sustain and grow the dividend, supported by a business that supplies essential diagnostic tools including CT and MR imaging systems, contrast media pharmaceuticals, and patient monitoring equipment across a broad international customer base. GE HealthCare Technologies Inc. dividend safety benefits from this low retention demand on earnings, though the company's short dividend history of four years means there is limited data to assess how the payout holds up through a full business cycle.
GE HealthCare Technologies Inc. dividend history shows a CAGR of 16.7% per year from 2024 to 2025. The per-share annual dividend grew from $0.12 to $0.14 over that period (2026 data is partial and excluded from the growth calculation). The smallest annual increase in the window was 16.7% in 2025, which is also the only complete increase on record. For income investors, that growth rate is meaningful, but the one-year window is too short to confirm it as a pattern.
GEHC fits growth-and-income investors who prioritize dividend growth over current yield, not those seeking immediate income from a medical technology holding. The yield is low (below 2%), sitting at 0.21% today, slightly above the 5-year average of 0.18% but not by a margin that changes the income picture. What the stock offers instead is a 4.3% payout ratio that leaves room for continued increases, and a 16.7% growth rate on the one complete year of increase data available. The trade-off is clear: income is minimal now, and the dividend history is too short to confirm whether that growth rate holds.
| Payment Date | Amount per Share |
|---|---|
| 2026-07-24 | $0.0350 |
| 2026-04-02 | $0.0350 |
| 2026-01-09 | $0.0350 |
| 2025-10-24 | $0.0350 |
| 2025-07-25 | $0.0350 |
| 2025-04-25 | $0.0350 |
| 2025-01-14 | $0.0350 |
| 2024-10-18 | $0.0300 |
| 2024-07-19 | $0.0300 |
| 2024-04-18 | $0.0300 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.1050 |
| 2025 | $0.1400 |
| 2024 | $0.1200 |
| 2023 | $0.0900 |
Project income from GEHC with the GEHC dividend calculator or track your full portfolio with the dividend tracker.